A question on all these deals:
At this stage PYC have penned 4 initial colaberation deals to identify certain peptides, which have reported progressed well. No small achievement by any means.
But, none of them have really stepped up and gone to the next stage. We've got Pfizer, Medimmune and Roche having all gone through the initial stages but no further.
When are these guys supossed to step up, or not? Be nice to get confirmation of the science been taken seriously as opossed to having companies just looking throug hthe door.
BTW, word is that Roche might not be taking their collaberation forward...? Anyone else hear anything good, bad or indifferent?
A question on all these deals:At this stage PYC have penned 4...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.42 |
Change
0.030(2.16%) |
Mkt cap ! $828.2M | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.42 | $1.35 | $262.9K | 189.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7220 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.42 | 31411 | 3 |
View Market Depth
| Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |